Exhibit 99.2
THE TIMKEN COMPANY AND SUBSIDIARIES
CONDENSED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
The following unaudited condensed pro forma consolidated financial statements are based upon the historical financial statements of The Timken Company (“the Company”) and its subsidiaries, adjusted to reflect the disposition of the Needle Roller Bearings (NRB) business which was completed on December 31, 2009. The following unaudited condensed pro forma consolidated financial statements of the Company should be read in conjunction with the related notes and with the historical consolidated financial statements of the Company and the related notes included in previous filings with the Securities and Exchange Commission. The unaudited condensed pro forma consolidated balance sheet reflects the disposition of the NRB business as if it had occurred on September 30, 2009, while the unaudited condensed pro forma statements of consolidated income for the years ended December 31, 2008, December 31, 2007 and December 31, 2006, respectively, give effect to the disposition as if it had occurred at the beginning of each period presented. The pro forma adjustments, described in the related notes, are based on the best available information and certain assumptions that the Company’s management believes to be reasonable. Pro forma statements of consolidated income for the nine months ended September 30, 2009 are not provided, as the Form 10Q filed on November 9, 2009 reflects the NRB operations as discontinued operations.
The unaudited condensed pro forma consolidated financial statements are provided for illustrative purposes only and are not necessarily indicative of the operating results or financial position that would have occurred had the disposition of the NRB business closed on September 30, 2009 for the unaudited condensed pro forma consolidated balance sheet or at the beginning of each period presented for the unaudited condensed pro forma statements of consolidated income.
Condensed Pro Forma Consolidated Balance Sheet
September 30, 2009
(unaudited)
| | | | | | | | | | | | |
| | | | | | Pro Forma | | |
(Dollars in thousands) | | Historical | | Adjustments | | Pro Forma |
|
| | | | | | | | | | | | |
ASSETS | | | | | | | | | | | | |
Current Assets | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 382,878 | | | $ | 299,698 | | (a) | $ | 682,576 | |
Restricted cash | | | 248,158 | | | | — | | | | 248,158 | |
Accounts receivable, net | | | 458,393 | | | | — | | | | 458,393 | |
Inventories, net | | | 716,948 | | | | — | | | | 716,948 | |
Deferred income taxes | | | 69,633 | | | | — | | | | 69,633 | |
Deferred charges and prepaid expenses | | | 17,536 | | | | — | | | | 17,536 | |
Current assets, discontinued operations | | | 364,494 | | | | (364,494 | ) | (b) | | — | |
Other current assets | | | 58,657 | | | | 15,855 | | (c) | | 74,512 | |
|
Total Current Assets | | | 2,316,697 | | | | (48,941 | ) | | | 2,267,756 | |
| | | | | | | | | | | | |
Property, Plant and Equipment | | | 3,654,951 | | | | — | | | | 3,654,951 | |
Less allowances for depreciation | | | (2,228,991 | ) | | | — | | | | (2,228,991 | ) |
|
Property, Plant and Equipment, net | | | 1,425,960 | | | | — | | | | 1,425,960 | |
| | | | | | | | | | | | |
Other Assets | | | | | | | | | | | | |
Goodwill | | | 222,225 | | | | — | | | | 222,225 | |
Other intangible assets | | | 134,437 | | | | — | | | | 134,437 | |
Deferred income taxes | | | 310,928 | | | | (4,743 | ) | (d) | | 306,185 | |
Other non-current assets | | | 47,774 | | | | — | | | | 47,774 | |
|
Total Other Assets | | | 715,364 | | | | (4,743 | ) | | | 710,621 | |
|
Total Assets | | $ | 4,458,021 | | | $ | (53,684 | ) | | $ | 4,404,337 | |
|
| | | | | | | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | | | | | | |
Current Liabilities | | | | | | | | | | | | |
Accounts payable and other liabilities | | $ | 352,558 | | | $ | 11,886 | | (e) | $ | 364,444 | |
Short-term debt and current portion of long-term debt | | | 331,860 | | | | — | | | | 331,860 | |
Income taxes payable | | | — | | | | — | | | | — | |
Deferred income taxes | | | 5,060 | | | | — | | | | 5,060 | |
Current liabilities, discontinued operations | | | 44,181 | | | | (44,181 | ) | (f) | | — | |
Salaries, wages and benefits | | | 147,848 | | | | — | | | | 147,848 | |
|
Total Current Liabilities | | | 881,507 | | | | (32,295 | ) | | | 849,212 | |
| | | | | | | | | | | | |
Non-Current Liabilities | | | | | | | | | | | | |
Long-term debt | | | 469,057 | | | | — | | | | 469,057 | |
Accrued pension cost | | | 786,545 | | | | — | | | | 786,545 | |
Accrued postretirement benefits cost | | | 611,743 | | | | (3,399 | ) | (g) | | 608,344 | |
Other non-current liabilities | | | 118,196 | | | | — | | | | 118,196 | |
|
Total Non-Current Liabilities | | | 1,985,541 | | | | (3,399 | ) | | | 1,982,142 | |
| | | | | | | | | | | | |
Shareholders’ Equity | | | | | | | | | | | | |
Common Stock | | | 892,783 | | | | — | | | | 892,783 | |
Earnings invested in the business | | | 1,431,701 | | | | (4,179 | ) | (h) | | 1,427,522 | |
Accumulated other comprehensive loss | | | (747,157 | ) | | | (13,811 | ) | (i) | | (760,968 | ) |
Treasury Shares | | | (4,493 | ) | | | — | | | | (4,493 | ) |
|
Total Shareholders’ Equity | | | 1,572,834 | | | | (17,990 | ) | | | 1,554,844 | |
|
Noncontrolling interest | | | 18,139 | | | | — | | | | 18,139 | |
|
Total Equity | | | 1,590,973 | | | | (17,990 | ) | | | 1,572,983 | |
|
Total Liabilities and Shareholders’ Equity | | $ | 4,458,021 | | | $ | (53,684 | ) | | $ | 4,404,337 | |
|
See Notes to Unaudited Condensed Pro Forma Financial Statements.
Condensed Pro Forma Statement of Consolidated Income
Year ended December 31, 2008
(unaudited)
| | | | | | | | | | | | |
| | | | | | Pro Forma | | |
(Dollars in thousands, except per share data) | | Historical | | Adjustments (j) | | Pro Forma |
|
| | | | | | | | | | | | |
Net sales | | $ | 5,663,660 | | | $ | (622,860 | ) | | $ | 5,040,800 | |
Cost of products sold | | | 4,422,191 | | | | (533,244 | ) | | | 3,888,947 | |
|
Gross Profit | | | 1,241,469 | | | | (89,616 | ) | | | 1,151,853 | |
| | | | | | | | | | | | |
Selling, administrative and general expenses | | | 724,987 | | | | (67,856 | ) | | | 657,131 | |
Impairment and restructuring charges | | | 64,383 | | | | (31,593 | ) | | | 32,790 | |
Gain on divestitures | | | (8 | ) | | | — | | | | (8 | ) |
|
Operating Income | | | 452,107 | | | | 9,833 | | | | 461,940 | |
| | | | | | | | | | | | |
Interest expense | | | (44,934 | ) | | | 533 | | | | (44,401 | ) |
Interest income | | | 5,971 | | | | (179 | ) | | | 5,792 | |
Receipt of Continued Dumping & Subsidy Offset Act (CDSOA) payment, net of expenses | | | 10,207 | | | | (1,071 | ) | | | 9,136 | |
Other expense — net | | | 5,827 | | | | 1,292 | | | | 7,119 | |
|
Income from continuing operations before income taxes | | | 429,178 | | | | 10,408 | | | | 439,586 | |
Provision for income taxes | | | 157,926 | | | | (865 | ) | | | 157,061 | |
|
Income from continuing operations | | $ | 271,252 | | | $ | 11,273 | | | $ | 282,525 | |
|
| | | | | | | | | | | | |
Earnings per share from continuing operations | | | | | | | | | | | | |
Basic | | $ | 2.82 | | | | | | | $ | 2.93 | |
Diluted | | | 2.81 | | | | | | | | 2.93 | |
| | | | | | | | | | | | |
Average common shares outstanding | | | | | | | | | | | | |
Basic | | | 95,650,104 | | | | | | | | 95,650,104 | |
Diluted | | | 95,947,643 | | | | | | | | 95,947,643 | |
See Notes to Unaudited Condensed Pro Forma Financial Statements.
Condensed Pro Forma Statement of Consolidated Income
Year ended December 31, 2007
(unaudited)
| | | | | | | | | | | | |
| | | | | | Pro Forma | | |
(Dollars in thousands, except per share data) | | Historical | | Adjustments (j) | | Pro Forma |
|
Net sales | | $ | 5,236,020 | | | $ | (703,954 | ) | | $ | 4,532,066 | |
Cost of products sold | | | 4,182,186 | | | | (605,103 | ) | | | 3,577,083 | |
|
Gross Profit | | | 1,053,834 | | | | (98,851 | ) | | | 954,983 | |
| | | | | | | | | | | | |
Selling, administrative and general expenses | | | 695,283 | | | | (64,121 | ) | | | 631,162 | |
Impairment and restructuring charges | | | 40,378 | | | | (11,973 | ) | | | 28,405 | |
Loss on divestitures | | | 528 | | | | — | | | | 528 | |
|
Operating Income | | | 317,645 | | | | (22,757 | ) | | | 294,888 | |
| | | | | | | | | | | | |
Interest expense | | | (42,684 | ) | | | 370 | | | | (42,314 | ) |
Interest income | | | 7,045 | | | | (109 | ) | | | 6,936 | |
Receipt of Continued Dumping & Subsidy Offset Act (CDSOA) payment, net of expenses | | | 7,854 | | | | (1,405 | ) | | | 6,449 | |
Other expense — net | | | (4,001 | ) | | | 2,697 | | | | (1,304 | ) |
|
Income from continuing operations before income taxes | | | 285,859 | | | | (21,204 | ) | | | 264,655 | |
Provision for income taxes | | | 62,868 | | | | (8,927 | ) | | | 53,941 | |
|
Income from continuing operations | | $ | 222,991 | | | $ | (12,277 | ) | | $ | 210,714 | |
|
| | | | | | | | | | | | |
Earnings per share from continuing operations | | | | | | | | | | | | |
Basic | | $ | 2.34 | | | | | | | $ | 2.21 | |
Diluted | | | 2.32 | | | | | | | | 2.19 | |
| | | | | | | | | | | | |
Average common shares outstanding | | | | | | | | | | | | |
Basic | | | 94,639,065 | | | | | | | | 94,639,065 | |
Diluted | | | 95,281,799 | | | | | | | | 95,281,799 | |
See Notes to Unaudited Condensed Pro Forma Financial Statements.
Condensed Pro Forma Statement of Consolidated Income
Year ended December 31, 2006
(unaudited)
| | | | | | | | | | | | |
| | | | | | Pro Forma | | |
(Dollars in thousands, except per share data) | | Historical | | Adjustments (j) | | Pro Forma |
|
Net sales | | $ | 4,973,365 | | | $ | (696,971 | ) | | $ | 4,276,394 | |
Cost of products sold | | | 3,968,271 | | | | (585,100 | ) | | | 3,383,171 | |
|
Gross Profit | | | 1,005,094 | | | | (111,871 | ) | | | 893,223 | |
| | | | | | | | | | | | |
Selling, administrative and general expenses | | | 677,342 | | | | (66,159 | ) | | | 611,183 | |
Impairment and restructuring charges | | | 44,881 | | | | (13,933 | ) | | | 30,948 | |
Loss on divestitures | | | 64,271 | | | | — | | | | 64,271 | |
|
Operating Income | | | 218,600 | | | | (31,779 | ) | | | 186,821 | |
| | | | | | | | | | | | |
Interest expense | | | (49,387 | ) | | | 350 | | | | (49,037 | ) |
Interest income | | | 4,605 | | | | 867 | | | | 5,472 | |
Receipt of Continued Dumping & Subsidy Offset Act (CDSOA) payment, net of expenses | | | 87,907 | | | | (20,328 | ) | | | 67,579 | |
Other expense — net | | | (4,148 | ) | | | 1,946 | | | | (2,202 | ) |
|
Income from continuing operations before income taxes | | | 257,577 | | | | (48,944 | ) | | | 208,633 | |
Provision for income taxes | | | 77,795 | | | | (15,320 | ) | | | 62,475 | |
|
Income from continuing operations | | $ | 179,782 | | | $ | (33,624 | ) | | $ | 146,158 | |
|
| | | | | | | | | | | | |
Earnings per share from continuing operations | | | | | | | | | | | | |
Basic | | $ | 1.91 | | | | | | | $ | 1.55 | |
Diluted | | | 1.90 | | | | | | | | 1.54 | |
| | | | | | | | | | | | |
Average common shares outstanding | | | | | | | | | | | | |
Basic | | | 93,325,729 | | | | | | | | 93,325,729 | |
Diluted | | | 94,092,657 | | | | | | | | 94,092,657 | |
See Notes to Unaudited Condensed Pro Forma Financial Statements.
THE TIMKEN COMPANY AND SUBSIDIARIES
NOTES TO CONDENSED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
| (a) | | Reflects the gross proceeds of $330 million, less the value of certain receivables and payables retained by the Company, from the sale of the Needle Roller Bearings (NRB) business. In addition, pursuant to the Sale and Purchase Agreement (the “Purchase Agreement”), cash is excluded from assets transferred to the Buyer. |
|
| (b) | | Reflects the elimination of assets of the NRB business acquired by the Buyer, net of assets that will be retained by the Company, in accordance with the Purchase Agreement. |
|
| (c) | | Reflects the estimated current tax benefit from the loss on the sale of the NRB business. |
|
| (d) | | Reflects adjustments to deferred taxes resulting from the sale of the NRB business. |
|
| (e) | | Reflects transaction costs and transfer taxes, as well as adjustments for property taxes, as a result of the sale of the NRB business. |
|
| (f) | | Reflects the elimination of liabilities of the NRB business that transfer to the Buyer in accordance with the Purchase Agreement. |
|
| (g) | | Reflects an adjustment to the curtailment of the Company’s postretirement medical plan. |
|
| (h) | | Reflects the after-tax pro forma impact of the loss on the sale of the NRB business, assuming an estimated effective tax rate of 69%. The Company expects to incur an after-tax loss on the sale of the NRB business of up to approximately $10 million upon completion of the sale. The expected loss is only an estimate and is subject to change based on the final balance sheet amounts and jurisdictional tax computations, as of the effective date of the sale. |
|
| (i) | | Reflects the elimination of pension adjustments, net of deferred taxes, associated with certain pension plans of the NRB business that transfer to the Buyer and foreign currency translation adjustments associated with the NRB business. |
|
| (j) | | Reflects the elimination of the operating results of the NRB business as if the transaction occurred at the beginning of the each period presented. These results have been adjusted to reflect federal and state income taxes of the NRB business on a stand-alone basis. The pro forma loss on the sale of the NRB business is not reflected in the pro forma statements of consolidated income. |